Consolidated cash flow statements

Unaudited condensed consolidated interim financial statements

(unaudited)

 

Nine months ended 30 September

(thousands of €)

2018

2017

Cash and cash equivalents at beginning of year

1,151,211

973,241

 

 

 

Net loss

(44,215)

(85,855)

 

 

 

Adjustments for:

 

 

Tax income (–) / tax expense

(343)

161

Net financial income (–) / expense

(8,958)

23,142

Depreciation of property, plant and equipment

2,843

2,701

Amortization of intangible fixed assets

1,973

510

Net realized loss on foreign exchange transactions and other financial expenses paid

(352)

(503)

Share-based compensation

18,001

11,697

Decrease in provisions

(8)

(8)

Increase in pension liabilities

236

214

Loss on disposal of financial asset held at fair value through profit or loss

3

 

 

 

 

 

(30,820)

(47,942)

 

 

 

Increase in inventories

(1)

(3)

Increase in receivables

(3,317)

(8,240)

Increase in payables

30,371

16,464

Decrease in deferred income

(93,370)

(47,180)

 

 

 

Cash used in operations

(97,137)

(86,901)

 

 

 

Interest paid

(1,026)

(42)

Interest received

3,252

903

Income taxes paid

(7)

(191)

 

 

 

Net cash flows used in operating activities

(94,918)

(86,231)

 

 

 

Purchase of property, plant and equipment

(4,259)

(2,986)

Purchase of and expenditure in intangible fixed assets

(1,533)

(233)

Proceeds from disposal of property, plant and equipment

1

Decrease in restricted cash

6,453

Proceeds from sale of financial asset held at fair value through profit or loss

134

372

 

 

 

Net cash flows generated / used (–) in investing activities

(5,657)

3,605

 

 

 

Repayment of obligations under finance leases and other debts

(6)

(50)

Proceeds from capital and share premium increases, gross amount

296,188

363,924

Issue costs paid related to capital and share premium increases

(15,008)

(15,790)

Proceeds from capital and share premium increases from exercise of warrants

5,261

4,935

 

 

 

Net cash flows generated in financing activities

286,435

353,018

 

 

 

Effect of exchange rate differences on cash and cash equivalents

6,596

(24,777)

 

 

 

Increase in cash and cash equivalents

192,456

245,615

 

 

 

Cash and cash equivalents at end of the period

1,343,668

1,218,856

The accompanying notes form an integral part of these condensed consolidated financial statements.